JAGSONPAL PHARMACEUTICALS
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity - Authorised | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity - Issued | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Paid Up | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
Share Warrants & Outstandings | ₹17 Cr | ₹8.77 Cr | - | - | - |
Total Reserves | ₹157 Cr | ₹137 Cr | ₹120 Cr | ₹109 Cr | ₹98 Cr |
Securities Premium | ₹11 Cr | ₹0.60 Cr | ₹0.60 Cr | ₹0.60 Cr | ₹0.60 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹104 Cr | ₹95 Cr | ₹69 Cr | ₹59 Cr | ₹48 Cr |
General Reserves | ₹42 Cr | ₹42 Cr | ₹42 Cr | ₹42 Cr | ₹42 Cr |
Other Reserves | - | ₹0.09 Cr | ₹7.89 Cr | ₹7.84 Cr | ₹7.84 Cr |
Reserve excluding Revaluation Reserve | ₹157 Cr | ₹137 Cr | ₹120 Cr | ₹101 Cr | ₹90 Cr |
Revaluation reserve | - | - | - | ₹7.84 Cr | ₹7.84 Cr |
Shareholder's Funds | ₹187 Cr | ₹159 Cr | ₹133 Cr | ₹122 Cr | ₹111 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | - | - | - |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹2.07 Cr | ₹2.16 Cr | ₹3.24 Cr | ₹1.86 Cr | ₹3.09 Cr |
Deferred Tax Assets | ₹2.25 Cr | ₹1.53 Cr | ₹0.86 Cr | ₹0.25 Cr | - |
Deferred Tax Liability | ₹4.32 Cr | ₹3.70 Cr | ₹4.10 Cr | ₹2.11 Cr | ₹3.09 Cr |
Other Long Term Liabilities | ₹7.56 Cr | ₹5.25 Cr | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹0.92 Cr | ₹1.08 Cr | ₹1.26 Cr | ₹0.02 Cr | - |
Total Non-Current Liabilities | ₹11 Cr | ₹8.49 Cr | ₹4.49 Cr | ₹1.88 Cr | ₹3.09 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹7.60 Cr | ₹17 Cr | ₹19 Cr | ₹18 Cr | ₹12 Cr |
Sundry Creditors | ₹7.60 Cr | ₹17 Cr | ₹19 Cr | ₹18 Cr | ₹12 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹11 Cr | ₹11 Cr | ₹7.70 Cr | ₹11 Cr | ₹8.16 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.29 Cr | ₹0.61 Cr | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹9.49 Cr | ₹9.98 Cr | ₹7.70 Cr | ₹11 Cr | ₹8.16 Cr |
Short Term Borrowings | - | - | - | ₹6.79 Cr | ₹6.40 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | - | - | - | ₹6.79 Cr | ₹6.40 Cr |
Short Term Provisions | ₹9.26 Cr | ₹8.01 Cr | ₹7.89 Cr | ₹4.67 Cr | ₹8.30 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹8.51 Cr | ₹7.63 Cr | ₹7.40 Cr | ₹3.82 Cr | ₹8.30 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.75 Cr | ₹0.38 Cr | ₹0.49 Cr | ₹0.85 Cr | - |
Total Current Liabilities | ₹28 Cr | ₹35 Cr | ₹34 Cr | ₹40 Cr | ₹35 Cr |
Total Liabilities | ₹226 Cr | ₹203 Cr | ₹171 Cr | ₹164 Cr | ₹149 Cr |
ASSETS | |||||
Gross Block | ₹12 Cr | ₹33 Cr | ₹58 Cr | ₹60 Cr | ₹58 Cr |
Less: Accumulated Depreciation | ₹2.29 Cr | ₹8.59 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹9.30 Cr | ₹24 Cr | ₹23 Cr | ₹26 Cr | ₹24 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | ₹1.90 Cr |
Non Current Investments | - | ₹1.12 Cr | ₹29 Cr | ₹12 Cr | ₹11 Cr |
Long Term Investment | - | ₹1.12 Cr | ₹29 Cr | ₹12 Cr | ₹11 Cr |
Quoted | - | ₹0.10 Cr | ₹0.10 Cr | ₹0.00 Cr | ₹0.00 Cr |
Unquoted | - | ₹1.02 Cr | ₹29 Cr | ₹12 Cr | ₹11 Cr |
Long Term Loans & Advances | ₹1.72 Cr | ₹0.69 Cr | ₹1.07 Cr | ₹5.66 Cr | ₹15 Cr |
Other Non Current Assets | ₹6.81 Cr | ₹4.30 Cr | ₹2.62 Cr | ₹0.29 Cr | ₹0.13 Cr |
Total Non-Current Assets | ₹18 Cr | ₹30 Cr | ₹55 Cr | ₹44 Cr | ₹52 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | ₹22 Cr | ₹3.25 Cr | - |
Quoted | - | - | ₹22 Cr | ₹3.25 Cr | - |
Unquoted | - | - | - | - | - |
Inventories | ₹15 Cr | ₹21 Cr | ₹30 Cr | ₹30 Cr | ₹29 Cr |
Raw Materials | ₹6.02 Cr | ₹7.81 Cr | ₹13 Cr | ₹6.94 Cr | ₹1.26 Cr |
Work-in Progress | ₹1.26 Cr | ₹1.08 Cr | ₹2.70 Cr | ₹12 Cr | ₹5.96 Cr |
Finished Goods | ₹3.81 Cr | ₹4.72 Cr | ₹9.03 Cr | ₹10 Cr | ₹22 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | ₹0.01 Cr | - | - |
Other Inventory | ₹3.90 Cr | ₹7.07 Cr | ₹5.44 Cr | - | - |
Sundry Debtors | ₹11 Cr | ₹21 Cr | ₹16 Cr | ₹13 Cr | ₹21 Cr |
Debtors more than Six months | ₹1.38 Cr | ₹1.31 Cr | ₹0.69 Cr | ₹0.63 Cr | ₹0.50 Cr |
Debtors Others | ₹11 Cr | ₹20 Cr | ₹15 Cr | ₹12 Cr | ₹21 Cr |
Cash and Bank | ₹148 Cr | ₹115 Cr | ₹25 Cr | ₹60 Cr | ₹40 Cr |
Cash in hand | - | ₹0.05 Cr | ₹0.19 Cr | ₹0.31 Cr | ₹0.28 Cr |
Balances at Bank | ₹148 Cr | ₹115 Cr | ₹25 Cr | ₹60 Cr | ₹40 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1.36 Cr | ₹1.15 Cr | ₹1.41 Cr | ₹0.27 Cr | ₹0.53 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹1.36 Cr | ₹1.07 Cr | ₹1.06 Cr | - | - |
Other current_assets | - | ₹0.09 Cr | ₹0.34 Cr | ₹0.27 Cr | ₹0.53 Cr |
Short Term Loans and Advances | ₹15 Cr | ₹15 Cr | ₹22 Cr | ₹14 Cr | ₹4.52 Cr |
Advances recoverable in cash or in kind | ₹2.23 Cr | ₹4.20 Cr | ₹8.65 Cr | ₹8.32 Cr | - |
Advance income tax and TDS | ₹8.51 Cr | ₹7.61 Cr | ₹7.17 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹4.60 Cr | ₹3.04 Cr | ₹6.65 Cr | ₹6.01 Cr | ₹4.52 Cr |
Total Current Assets | ₹191 Cr | ₹172 Cr | ₹116 Cr | ₹120 Cr | ₹96 Cr |
Net Current Assets (Including Current Investments) | ₹163 Cr | ₹137 Cr | ₹82 Cr | ₹80 Cr | ₹62 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹226 Cr | ₹203 Cr | ₹171 Cr | ₹164 Cr | ₹149 Cr |
Contingent Liabilities | ₹11 Cr | ₹6.09 Cr | ₹7.96 Cr | ₹8.08 Cr | ₹6.06 Cr |
Total Debt | - | - | - | ₹6.79 Cr | ₹6.40 Cr |
Book Value | 64.43 | 57.30 | 50.68 | 43.55 | 39.39 |
Adjusted Book Value | 64.43 | 57.30 | 50.68 | 43.55 | 39.39 |
Compare Balance Sheet of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,583.4 Cr | -2.6% | -4.9% | 57.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹451,603.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,862.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹122,810.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,946.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,377.1 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | -2.6% |
-4.9% |
57.9% |
SENSEX | 0.3% |
-2.5% |
10% |
You may also like the below Video Courses